INTELLIGENT BIO SOLUTIONS INC.
INBSdata completeness 88%7 fiscal years on fileData notes: no data for concept 'investmentsAtFairValue'; no data for concept 'netInvestmentIncome'; no data for concept 'gainsOnRealEstateSales'; no data for concept 'dividendsPaid'; no data for concept 'interestExpense'; no data for concept 'incomeTaxExpense'
INTELLIGENT BIO SOLUTIONS INC. earns about -221% on equity, but has diluted owners by 101% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | $437,1461 | $1.26M2 | $3.11M3 | $3.05M4 | $4.22M4 |
| Net income | −$8.31M5 | −$10.6M6 | −$10.2M7 | −$10.6M8 | −$12.4M8 |
| Operating cash flow | −$3.36M9 | −$7.38M10 | −$9.57M11 | −$9.68M12 | −$11.9M12 |
| Capital expenditure | — | — | $221,42613 | $231,83814 | $125,73114 |
| Free cash flow (derived) | — | — | −$9.79M11 | −$9.91M12 | −$12.1M12 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $8.24M15 | $1.54M16 | $6.3M17 | $1.02M18 | $3.99M18 |
| Diluted shares | 733,263 | 83,717 | 1.6M | 527,364 | 1.5M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $37.42 of net worth that earned you −$84.41 and generated −$81.84 of cash last year.
It earned an average -221% on equity over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 101% over 5 years — owners have been diluted. Worth asking what they got for it.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-06-30 · accession 0001493152-22-026526 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2025-06-30 · accession 0001493152-26-039136 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-06-30 · accession 0001493152-23-029992 (NetIncomeLoss)
- 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (NetIncomeLoss)
- 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (NetIncomeLoss)
- 10-K · period ending 2025-06-30 · accession 0001493152-26-039136 (NetIncomeLoss)
- 10-K · period ending 2022-06-30 · accession 0001493152-23-029992 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2025-06-30 · accession 0001493152-26-039136 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2025-06-30 · accession 0001493152-26-039136 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-06-30 · accession 0001493152-23-029992 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-06-30 · accession 0001493152-24-036953 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-06-30 · accession 0001641172-25-024279 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2025-06-30 · accession 0001493152-26-039136 (CashAndCashEquivalentsAtCarryingValue)